
Computacenter
OrganizationHeard in 4 episodes across 2 shows since Jul 2026
Computacenter plc is a British multinational company that provides information technology services to public- and private-sector customers. Headquartered in Hatfield, Hertfordshire, the company helps organizations source, transform, and manage their technology infrastructure.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 1 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 1 |
| Nov 2026 | 0 |
Email alert
Email me when Computacenter comes up on a podcast
One email a week at most, with the new episodes that mention Computacenter. Free, no account needed, unsubscribe in one click.
What experts have said about Computacenter
4 statements · 4 positive
Computacenter may exemplify Britain’s AI opportunity.
“Computer Centre might be one of the shining examples of that in a UK context”
Open the episode · Novartis Slumps, Rubis Gains, Computacenter UpListen at 3:22
Computacenter is a lesser-known beneficiary of AI investment.
“Computer Centre is essentially one of those slightly lesser known AI. winners”
Open the episode · Novartis Slumps, Sandoz Gains, Computacenter UpListen at 3:59
Computacenter shares may have further upside.
“it seems that there might be even further to go for a computer center”
Open the episode · Novartis Slumps, Sandoz Gains, Computacenter UpListen at 4:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Computacenter, newest first
- Oct 26, 2026
Computacenter lifts outlook as UK market roundup turns positiveUK Small/Mid Caps with Paul ScottOct 26, 2026 - Sep 8, 2026
Drug setbacks hit Novartis as AI demand lifts ComputacenterStock MoversSep 8, 2026 - Sep 8, 2026
European stocks split between clinical risk and AI demandStock MoversSep 8, 2026 - Jul 9, 2026
Deutz bets on defense as AstraZeneca trial disappointsStock MoversJul 9, 2026